发布求助
文献互助 智能选刊 最新文献

Regular and Young Investigator Award Abstracts最新文献

筛选
英文 中文
236 Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the successful expansion factors for developing adoptive cell therapy 头颈部鳞状细胞癌肿瘤浸润淋巴细胞的扩增，以评估发展过继细胞治疗的成功扩增因子
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0236
M. Hossain, Jong Hyeok Kim, Hyun Lee, C. Lim, G. Gong, H. Lee
{"title":"236 Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the successful expansion factors for developing adoptive cell therapy","authors":"M. Hossain, Jong Hyeok Kim, Hyun Lee, C. Lim, G. Gong, H. Lee","doi":"10.1136/jitc-2022-sitc2022.0236","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0236","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"68 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125974010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
168 Exploring features and parameters for neighborhood analysis in human cancer multiplexed immunofluorescence data 168探索人类癌症多路免疫荧光数据邻域分析的特征和参数
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0168
Ian Dryg, M. Turner, Ann-Elizabeth Le, Anne Carlisle, Kathleen L. Pfaff, Jason L. Weirather, F. Stephen Hodi, S. Rodig
{"title":"168 Exploring features and parameters for neighborhood analysis in human cancer multiplexed immunofluorescence data","authors":"Ian Dryg, M. Turner, Ann-Elizabeth Le, Anne Carlisle, Kathleen L. Pfaff, Jason L. Weirather, F. Stephen Hodi, S. Rodig","doi":"10.1136/jitc-2022-sitc2022.0168","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0168","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121912384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
532 Anti-VISTA antibody HMBD-002 reprograms tumour associated macrophages and promotes cytotoxic T cell response 抗vista抗体HMBD-002重编程肿瘤相关巨噬细胞并促进细胞毒性T细胞反应
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0532
B. Dharmadhikari, D. Thakkar, O. Zharkova, Debleena Ray, Jason Lai, Konrad H. Paszkiewicz, P. Ingram, J. Boyd-Kirkup
{"title":"532 Anti-VISTA antibody HMBD-002 reprograms tumour associated macrophages and promotes cytotoxic T cell response","authors":"B. Dharmadhikari, D. Thakkar, O. Zharkova, Debleena Ray, Jason Lai, Konrad H. Paszkiewicz, P. Ingram, J. Boyd-Kirkup","doi":"10.1136/jitc-2022-sitc2022.0532","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0532","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122244793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
749 Use of positron emission tomography for the diagnosis of immune checkpoint inhibitor myocarditis 使用正电子发射断层扫描诊断免疫检查点抑制剂心肌炎
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0749
Nicolas L. Palaskas, Yang Lu, R. Caldwell, Praise Oderinde, G. Pina, Abdelrahman Ali, Khatera Shah, C. Iliescu, S. Yusuf, E. Koutroumpakis, Shaden Khalaf, Ihab Hamzeh, B. Siddiqui, S. Subudhi, A. Deswal
{"title":"749 Use of positron emission tomography for the diagnosis of immune checkpoint inhibitor myocarditis","authors":"Nicolas L. Palaskas, Yang Lu, R. Caldwell, Praise Oderinde, G. Pina, Abdelrahman Ali, Khatera Shah, C. Iliescu, S. Yusuf, E. Koutroumpakis, Shaden Khalaf, Ihab Hamzeh, B. Siddiqui, S. Subudhi, A. Deswal","doi":"10.1136/jitc-2022-sitc2022.0749","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0749","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121769021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
464 Anti-CTLA-4 therapy depletes Tregs and expands ICOS+T-cells in neuroblastoma tumors with induced DNA mismatch repair deficiency 464抗ctla -4治疗在诱导DNA错配修复缺陷的神经母细胞瘤肿瘤中消耗Tregs并扩大ICOS+ t细胞
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0464
Megan M Y Hong, R. Figueredo, Saman Maleki
{"title":"464 Anti-CTLA-4 therapy depletes Tregs and expands ICOS+T-cells in neuroblastoma tumors with induced DNA mismatch repair deficiency","authors":"Megan M Y Hong, R. Figueredo, Saman Maleki","doi":"10.1136/jitc-2022-sitc2022.0464","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0464","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115835118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumors 505肿瘤内骨髓细胞的高维分析突出了免疫检查点敏感和耐药肿瘤中不同骨髓细胞表型的存在
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0505
Swetha Anandhan, S. Goswami, Shelley M Herbrich, Yu-long Chen, P. Sharma
{"title":"505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumors","authors":"Swetha Anandhan, S. Goswami, Shelley M Herbrich, Yu-long Chen, P. Sharma","doi":"10.1136/jitc-2022-sitc2022.0505","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0505","url":null,"abstract":"Background Immune checkpoint therapy (ICT) has revolution-ized cancer treatment, however, has produced around 20% durable clinical response rates. 1 Multiple studies demonstrate myeloid cell abundance and function in the tumor microenvir-onment (TME) correlates with poor outcome in ICT resistant cancers. 2, 3 Despite the wealth of knowledge regarding the biology of these cells, our ability to distinguish immune-sup-pressive versus immune-stimulatory myeloid cells remains a major challenge and, thus, targeting myeloid cells has had lim-ited clinical success. Our objective is to better understand the phenotype of these immunosuppressive myeloid cells to identify potential combination strategies to improve response to ICT. Methods Comparative analyses of intratumoral myeloid cell subsets was performed in orthotopic murine models of ICT sensitive (B16F10 melanoma) and resistant (MT4 pancreatic) tumors at baseline and post ICT treatment (anti-PD-1 and/or anti-CTLA-4 antibodies) using single cell RNA sequencing (scRNAseq). To determine myeloid cell evolution with tumor progression, longitudinal scRNAseq was performed on MT4 tumors.","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131376297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1243 Immune checkpoint inhibitor-induced polyarthritis: a case series 免疫检查点抑制剂诱导的多发性关节炎:一个病例系列
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.1243
M. Smith-Uffen, K. Tselios
{"title":"1243 Immune checkpoint inhibitor-induced polyarthritis: a case series","authors":"M. Smith-Uffen, K. Tselios","doi":"10.1136/jitc-2022-sitc2022.1243","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.1243","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"126 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131920640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1248 Risk factors and a risk-scoring model for severe checkpoint inhibitor-related pneumonitis in lung cancer patients 肺癌患者严重检查点抑制剂相关性肺炎的1248个危险因素和风险评分模型
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.1248
H. Deng, Jiating Deng, Xinqing Lin, Chengzhi Zhou, Yanbin Zhou
{"title":"1248 Risk factors and a risk-scoring model for severe checkpoint inhibitor-related pneumonitis in lung cancer patients","authors":"H. Deng, Jiating Deng, Xinqing Lin, Chengzhi Zhou, Yanbin Zhou","doi":"10.1136/jitc-2022-sitc2022.1248","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.1248","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132037526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
126 Prognostic gene signature reflecting CD8+ T cell enrichment in early-stage triple-negative breast cancer 早期三阴性乳腺癌中CD8+ T细胞富集的预后基因特征
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.0126
Chang-Min Kim, Y. Yu, Jin-Young Park, K. Park
{"title":"126 Prognostic gene signature reflecting CD8+ T cell enrichment in early-stage triple-negative breast cancer","authors":"Chang-Min Kim, Y. Yu, Jin-Young Park, K. Park","doi":"10.1136/jitc-2022-sitc2022.0126","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.0126","url":null,"abstract":"Background Triple-negative breast cancer (TNBC) is the most challenging subtype of breast cancer, and its prognosis is poor compared to the other subtypes. 1 Immune cells have critical role in tumor rejection and prognosis of patient with TNBC. 2 In early TNBC, CD8+ T cells infiltration is positively associ-ated with response to neo-adjuvant chemotherapy and prognosis of patients. 3 Recently, combination of immune checkpoint inhibitor, pembrolizumab, with standard chemotherapy has been approved for the neo-adjuvant setting. 4 However, there are no valid prognostic biomarkers that reflect the CD8+ T cell enriched tumor in patients with early TNBC. To establish an elaborate therapeutic strategy for TNBC, identification of biomarkers that reflecting feature of CD8+ T cell enriched TNBC is needed. RNA conducted the gene expression of sam-ples Single performed signature","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132067895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1200 A clinically validated pH-sensitive nanomedicine platform for encapsulating therapeutic bispecific T cell engagers for tumor specific delivery and activation 一种经临床验证的ph敏感纳米药物平台，用于包封治疗性双特异性T细胞接合物，用于肿瘤特异性传递和激活
Regular and Young Investigator Award Abstracts Pub Date : 2022-11-01 DOI: 10.1136/jitc-2022-sitc2022.1200
Stephen Gutowski, Qingtai Su, Austin Burcham, Irina Kalashnikova, Ashley Campbell, Zirong Chen, Bhargavi Allu, Jason B. Miller, T. Zhao
{"title":"1200 A clinically validated pH-sensitive nanomedicine platform for encapsulating therapeutic bispecific T cell engagers for tumor specific delivery and activation","authors":"Stephen Gutowski, Qingtai Su, Austin Burcham, Irina Kalashnikova, Ashley Campbell, Zirong Chen, Bhargavi Allu, Jason B. Miller, T. Zhao","doi":"10.1136/jitc-2022-sitc2022.1200","DOIUrl":"https://doi.org/10.1136/jitc-2022-sitc2022.1200","url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130167016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信